Location History:
- North York, CA (2011)
- Toronto, CA (2020 - 2023)
Company Filing History:
4 out of 291 
3 out of 5 
2 out of 9 Years Active: 2011-2025
Title: Innovations in Cancer Research by Paul Boutros
Introduction
Paul Boutros is a prominent inventor based in Toronto, Canada, known for his significant contributions to cancer research. With a total of six patents, he has developed innovative methods that enhance the diagnosis and prognosis of cancer, particularly focusing on genetic analysis and treatment outcomes.
Latest Patents
One of his latest patents is titled "Cancer risk based on tumour clonality." This invention provides a method for diagnosing or prognosing a subject with cancer by utilizing cancer DNA sequencing data. The method involves comparing this data with control DNA sequencing data to identify genetic aberrations, determining clonal and subclonal populations, and constructing a phylogenetic map. This process allows for the assignment of a risk level associated with patient outcomes and responses to therapy. Another notable patent is "Gene signature of residual risk following endocrine treatment in early breast cancer." This method prognoses endocrine-only treatment by analyzing gene expression levels in tumor samples and comparing them to reference levels from control samples. The results help determine the residual risk associated with breast cancer.
Career Highlights
Paul Boutros has worked with esteemed organizations such as the University Health Network and the Ontario Institute for Cancer Research. His work in these institutions has been pivotal in advancing cancer research and developing innovative diagnostic methods.
Collaborations
Throughout his career, Paul has collaborated with notable professionals, including Robert G. Bristow and Shadrielle Melijah G. Espiritu. These collaborations have further enriched his research and contributed to the field of oncology.
Conclusion
Paul Boutros stands out as a leading inventor in cancer research, with his innovative patents significantly impacting the diagnosis and treatment of cancer. His work continues to inspire advancements in the medical field, ultimately aiming to improve patient outcomes.